Laurion Capital Management LP Madrigal Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $214,423 - $284,970	928 New	928 $224,000
Q1 2020 May 14, 2020	SELL	$66.76 - $93.49 $9.07 Million - $12.7 Million	-135,797 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$84.28 - $118.5 $11.1 Million - $15.6 Million	131,630 Added 3158.87%	135,797 $12.4 Million
Q3 2019 Nov 13, 2019	BUY	$84.4 - $106.53 $351,694 - $443,910	4,167 New	4,167 $359,000

335

22.3M

960K

940K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.75B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.